A simple method for estimating the optimum number of prostate biopsy cores needed to maintain high cancer detection rates while minimizing unnecessary biopsy sampling

Journal of Endourology

Volumn 24, Issue 1, 2010, Pages 143-147

  Jiang, Jimmy ^a   Colli, Janet ^a   El Galley, Rizk ^a  

^a Hugh Kaul Human Genetics Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

BIOPSY; EARLY DETECTION OF CANCER; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 75149180985     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0285     Document Type: Article

References (26)

1. American Cancer Society. Cancer facts and figures, 2008. www.cancer.org=docroot=home=index.asp
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-75.
4. Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology 1997;49:113-118.
5. Presti JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial. J Urol 2000;163:163-167.
6. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsy. J Urol 2000;163:158-162.
7. Stamey TA. Making the most out of systematic sextant biopsies. Urology 1995;45:2-12.
8. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-203.
9. Stamatiou K, Alevizos A, Karanasiou V, et al. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer. Urol Int 2007;78:313-317.
10. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166: 86-92.
11. Rabets JC, Jones JS, Patel A, et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 2004;172:94-97.
12. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: Impact on cancer detection. J Urol 2000;164:388-392.
13. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr. The influence of prostatic size on cancer detection. Urology 1995;46:831-836.
14. Letran JL, Meyer GE, Loberiza FR, Brawer MK. The effect of prostate volume on the yield of needle biopsy. J Urol 1998;160:1718-1721.
15. San Francisco IF, DeWolf WC, Rosen S, Upton M, Olumi AF. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 2003;169:136-140.
16. Mian BM, Lehr DJ, Moore CK, et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 2006;67:379-383.
17. King CR, McNeal JE, Gill H, Presti JC Jr. Extended prostate biopsy scheme improves reliability of Gleason grading: Implications for radiotherapy patients. Int J Radiat Oncol Biol Phys 2004;59:386-391.
18. Epstein JI, Sanderson H, Carter HB, Scharfstein DO. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology 2005;66:356-360.
19. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: A study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int 2004;94:1014-1020.
20. Rodríguez-Patrón Rodríguez RR, Mayayo Dehesa T, Burgos Revilla FJ, Alonso González M, García González R, Lennie Zucharino A. Tolerability and complications of the ultrasound guided transrectal biopsy of the prostate extended to 10 cores. The role of neurovascular bundle blockage with Lidocaine. Arch Esp Urol 2005;58:989-1001.
21. Vashi AR, Wojno KJ, Gillespie B, Oesterling JE. A model for the number of cores per prostate biopsy based on patient age and prostate gland. J Urol 1998;159:920-924.
22. Mariappan P, Chong WL, Sundram M, Mohamed SR. Increasing prostate biopsy cores based on volume vs the sextant biopsy:Aprospective randomized controlled clinical study on cancer detection rates and morbidity. BJU 2004;94:307-310.
23. Remzi M, Fong YK, Dobrovits M, et al. The Vienna nomogram: Validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. Urology 2005;174:1256-1260.
24. Patel AR, Jones JS, Rabets J, et al. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology 2004;63:87-89.
25. Ng TK, Vasilareas D, Mitterdorfer AJ, Maher PO, Lalak A. Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice. BJU Int 2005;95:545-548.
26. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.